Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary BioScrip To Host 2016 Second Quarter Results Call
DENVER , July 25, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) announced today that the Company will release its 2016 second quarter financial results on Monday, August 8, 2016 , before the opening of the U.S. financial markets. Richard M. Smith , President and Chief Executive Officer, and
Toggle Summary BioScrip Completes Public Offering of Common Stock
DENVER , June 22, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) (the “Company” or “BioScrip”) announced today that it has completed its previously announced underwritten public offering (the “Offering”) of 45,200,000 shares of its common stock, including 5,200,000 shares of common stock
Toggle Summary BioScrip Prices Underwritten Offering of Common Stock
DENVER, Colo. , June 16, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) (the “Company” or “BioScrip”) today announced the pricing of an underwritten offering of 40,000,000 shares of its common stock (the “Offering”) at a price to the public of $2.00 per share (the “Offering Price”).
Toggle Summary BioScrip and Home Solutions Enter Into Amended Agreement
Amendment Further Enhances Value for Shareholders Accretive Transaction Provides Substantial Operating Synergies and Deleveraging Opportunity DENVER and HAMMONTON, N.J., June 16, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of
Toggle Summary BioScrip Announces Transformative Acquisition of Home Solutions That Will Enhance Focus as Home Infusion Leader
Combination with Home Solutions Adds Experienced and Proven Leadership Team Accretive Transaction Provides Substantial Operating Synergies and Deleveraging Opportunity Enhances Focus on Higher Margin Core Infusion Therapies DENVER and HAMMONTON, N.J. , June 13, 2016 (GLOBE NEWSWIRE) -- BioScrip,
Toggle Summary BioScrip Announces Proposed Public Offering of Common Stock
DENVER , June 13, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) (the “Company” or “BioScrip”) today announced it has commenced an underwritten public offering of its common stock (the “Equity Offering”).  Jefferies LLC is acting as sole book-running manager.
Toggle Summary BioScrip Reports First Quarter 2016 Financial Results
DENVER , May 05, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) (“BioScrip” or the “Company”) today announced financial results for the first quarter 2016. For the first quarter, the Company reported revenue from continuing operations of $238.5 million , net loss from continuing operations
Toggle Summary BioScrip To Host 2016 First Quarter Results Call
DENVER , April 18, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) announced today that the Company will release its 2015 first quarter financial results on Thursday, May 5, 2016 , after the close of the U.S. financial markets. Richard M. Smith , President and Chief Executive Officer, and
Toggle Summary BioScrip Announces Filing of Shelf Registration Statement to Replace Expiring Registration Statement
DENVER , April 01, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) (“BioScrip” or the “Company”) today announced that, in order to replace its expiring registration statement,  it has filed to renew its current shelf registration statement on Form S-3 with the U.S.
Toggle Summary BioScrip Reports Fourth Quarter 2015 Financial Results
Q4 Consolidated Adjusted EBITDA of $9.0 Million Reaffirms 2016 Adjusted EBITDA Guidance of Between $50 Million - $60 Million DENVER , March 02, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) (“BioScrip” or the “Company”) today announced financial results for the fourth quarter and full year